Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicholas Colletti"'
Autor:
Hisham Qosa, Claudia H. M. C. deOliveira, Giovanni Cizza, Eric J. Lawitz, Nicholas Colletti, Jeffrey Wetherington, Edgar D. Charles, Giridhar S. Tirucherai
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1791-1802 (2023)
Abstract BMS‐986263 is a retinoid‐conjugated lipid nanoparticle delivering small interfering RNA designed to inhibit synthesis of HSP47 protein, a collagen‐specific chaperone protein involved in fibrosis development. This is a phase I, open‐l
Externí odkaz:
https://doaj.org/article/4e63f1a38b104278b07475928f2d40b4
Autor:
Karrie Wong, Sharon Lin, Christopher Wrocklage, Katri Sofjan, Leila Williams, Mallory Brady, Nicholas Colletti, Noah Tubo, Hugh Gannon, Robert LaMothe, Tianlei Xu, Tracy VandenBerg, Sol Shenker, Caroline Dugopolski, Frank Stegmeier, Louise Cadzow, Michael Schlabach, Micah Benson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/490a3e91b10d4fd1b0d7fff1fe4208ff
Autor:
Vincent Ollion, Ivan Perrot, Frédéric Montanana-Sanchis, Rabie Chelbi, Juliette Savoret, Thien-Phong Vu Manh, Bjarne Bogen, Nicholas Colletti, Christophe Caux, Even Fossum, Michael Shaw, Marc Dalod, Timothy Soos, Cindy Sanchez, Christian Chabannon, Anne-Claire Doffin, Sreekumar Balan, Hong Liu, Didier Bechlian, Jenny Valladeau-Guilemond, Carine Asselin-Paturel
Publikováno v:
The Journal of Immunology
Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1+ DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1+ hum